| dc.contributor.author |
Kosmas, C |
en |
| dc.contributor.author |
Epenetos, A |
en |
| dc.contributor.author |
Courtenay-Luck, N |
en |
| dc.date.accessioned |
2014-06-06T06:42:04Z |
|
| dc.date.available |
2014-06-06T06:42:04Z |
|
| dc.date.issued |
1991 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1038/bjc.1991.337 |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/403 |
|
| dc.subject |
B Cell |
en |
| dc.subject |
Case Study |
en |
| dc.subject |
Cell Proliferation |
en |
| dc.subject |
Monoclonal Antibody |
en |
| dc.subject |
Nk Cell |
en |
| dc.subject |
Peripheral Blood Mononuclear Cell |
en |
| dc.subject |
Statistical Significance |
en |
| dc.subject |
Immunoglobulin |
en |
| dc.subject |
Normal Control |
en |
| dc.subject |
Stimulation Index |
en |
| dc.subject |
T Helper |
en |
| dc.title |
Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1038/bjc.1991.337 |
en |
| heal.publicationDate |
1991 |
en |
| heal.abstract |
Peripheral blood mononuclear cells (PBMCs) were obtained from patients receiving radioactive murine monoclonal antibody (MAb) therapy for malignant epithelial tumours, as well as normal controls, and were tested for the ability of T cells to proliferate in vitro in the presence of the MAb administered for therapy (HMFG1), and another isotypically matched antibody of irrelevant specificity (11.4.1). We studied 13 |
en |
| heal.journalName |
British Journal of Cancer |
en |
| dc.identifier.doi |
10.1038/bjc.1991.337 |
en |